The significance of ERK5 catalytic-independent functions in disease pathways

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Extracellular signal-regulated kinase 5 (ERK5), also known as BMK1 or MAPK7, represents a recent addition to the classical mitogen-activated protein kinase (MAPK) family. This family includes well-known members such as ERK1/2, c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), as well as atypical MAPKs such as ERK3, ERK4, ERK7 (ERK8), and Nemo-like kinase (NLK). Comprehensive reviews available elsewhere provide detailed insights into ERK5, which interested readers can refer to for in-depth knowledge (Nithianandarajah-Jones et al., 2012; Monti et al., Cancers (Basel), 2022, 14). The primary aim of this review is to emphasize the essential characteristics of ERK5 and shed light on the intricate nature of its activation, with particular attention to the catalytic-independent functions in disease pathways.

Original languageEnglish (US)
Article number1235217
Pages (from-to)1235217
JournalFrontiers in Cell and Developmental Biology
Volume11
DOIs
StatePublished - 2023

Keywords

  • ERK5 activation
  • MAPK
  • S496 phosphorylation
  • SAS
  • SASP

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'The significance of ERK5 catalytic-independent functions in disease pathways'. Together they form a unique fingerprint.

Cite this